Developer docs
API playgroundTry for free, no card

Search company profiles

EarlyFit

Full company profile

uuid02c7rnx

Namestring
EarlyFit
Legal namestring
EarlyFit
Websiteurl
early.fit
Company typeenum
Private
Founded yearint
2025
Descriptiontext

EarlyFit, now operating as Voy India following its June 2026 acquisition by London-based Voy, runs a doctor-led digital weight loss platform that delivers GLP-1 obesity care to India's 150 million obese population. The core offering combines an online eligibility assessment, endocrinologist-led consultations, at-home cold-chain delivery of generic semaglutide medication, lifestyle coaching, at-home lab testing, and a companion mobile app with smart scale integration tracking 14+ body vitals. The business model is subscription-recurring, with bundled pricing that covers medication, ongoing medical oversight, and lifestyle support, backed by a money-back guarantee requiring 10% body weight loss within six months.

Founded by Parth and Saloni as one of India's first doctor-led GLP-1 ecosystems, EarlyFit was fully acquired by Voy on 2026-06-08 to bring Voy's global clinical expertise and integrated care model into the Indian market, timed to capitalize on the March 2026 expiration of Ozempic's patent in India. The medical team comprises senior endocrinologists trained at India's premier institutions — Apollo Delhi, AIIMS Delhi, AIIMS Jodhpur, Army Hospital, and Safdarjung — and global medical leadership under Dr. Earim Chaudry (Chief Medical Officer, Voy) and Dr. Saptarshi Bhattacharya (Chief Medical Advisor, Voy India). A clinical study of 57,975 Voy participants conducted with Imperial College London reports 53% more weight loss for Voy program users compared with medication-only treatment.

Go-to-market is product-led and digital: customers self-check eligibility online, download the mobile app (iOS/Android), enroll via subscription without sales intervention, and receive medication via door-to-door cold chain delivery. Distribution layers in doctor-consultation marketing and earned media across Indian publications (Indian Express, Times of India, Hindustan Times, News18, BioSpectrum India), with Trustpilot (4.7/5, 18k reviews) and App Store (4.8/5, 4.2k reviews) ratings functioning as trust signals. Strategic academic partnerships span Imperial College London, University of Oxford, University of Birmingham, Ulster University, University of Hertfordshire, and the Federal University of Minas Gerais, supporting clinical validation across Voy's four-country footprint (UK, Germany, Brazil, India).

Short descriptiontext

EarlyFit, now Voy India following Voy's June 2026 acquisition, runs a doctor-led digital GLP-1 weight loss platform serving India's 150 million obese population with endocrinologist consultations, cold-chain generic semaglutide delivery, and smart scale-integrated mobile app tracking.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersNew Delhi, India
HQ citystring
New Delhi
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Keyword5 values
online weight loss program, GLP-1 medication treatment, telehealth weight management, digital obesity care, doctor-supervised weight loss
Industry1 code
PRIMARYHSADAFAB
Weight Loss Coaching (Non-Clinical)
NAICS code1 code
  • Diet and Weight Reducing Centers812191
SIC code2 codes
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-Home Health Care Services8082
Product category
Digital Health / Telehealth Weight Management
No data
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1GLP-1 Medication Subscription
TypeSubscription Recurring
Description

Recurring subscription for GLP-1 medication (generic semaglutide) delivered to patients. Program includes doctor consultations, at-home medication delivery, side effect support, and lifestyle coaching. Following Ozempic's patent expiration in India in March 2026, affordable generic options are offered.

joinvoy.in
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Supply Chain, Others
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

EarlyFit is an online, doctor-supervised weight loss platform based in India that combines GLP-1 (semaglutide-based) medication programs with teleconsultations, at-home lab testing, and lifestyle coaching. The service delivers end-to-end obesity care via a mobile app and website, targeting individual adults seeking clinically-supervised weight management. Following its June 2026 acquisition by London-headquartered Voy, the offering now operates as Voy India.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 53% more weight loss compared to medication-only providers
+2 more records
Product overview1 text field

EarlyFit operates as a comprehensive digital weight loss platform offering a doctor-led GLP-1 obesity care program. The platform combines an online weight loss platform with mobile app functionality, providing medical consultations with endocrinologists, at-home GLP-1 medication delivery via cold chain, lifestyle coaching, smart body tracking, and at-home lab testing. Following its acquisition by UK-based Voy, the program now offers affordable generic semaglutide medications with a 10% body weight loss money-back guarantee.

Product and service5 records
1GLP-1 Weight Loss Program
CategoryWeight Management / Obesity Care
Description

A structured, doctor-supervised treatment program using GLP-1 receptor agonist medication (semaglutide) for adults with overweight or obesity, including an initial consultation, prescription, follow-ups, and lifestyle coaching. Target users are individual consumers in India seeking medical weight loss.

2EarlyFit Mobile App
CategoryPatient-facing Digital Health Application
Description

A consumer mobile app that allows enrolled users to register, complete telehealth consultations with clinicians, track weight-loss progress, access coaching, and manage their treatment plan. Targeted at individual program participants in India.

3At-Home Lab Testing
CategoryDiagnostics / Health Testing
Description

A home-based diagnostic testing service that collects blood and metabolic markers from enrolled users to support safe prescribing and progress monitoring of the weight loss program. Target users are individual program participants.

4Lifestyle Coaching Program
CategoryWellness Coaching / Behavioral Health
Description

A digital lifestyle coaching program providing nutritional guidance, activity planning, and habit-change support to complement medical treatment. Targeted at individual adults enrolled in the weight loss program.

5Generic Semaglutide Medication
CategoryPharmaceutical / Prescribed Medication
Description

Generic semaglutide medication dispensed under clinician prescription to enrolled users as part of the weight loss program. Targeted at individual patients medically cleared for GLP-1 therapy.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-08
Description

Voy, a London-headquartered digital healthcare company and market leader in GLP-1 obesity care, acquired 100% of EarlyFit to enter the Indian market. The acquisition brings Voy's global clinical expertise, technology, and integrated care model to India's 150 million obese population.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research partnership for clinical studies on GLP-1 weight loss outcomes. Conducted study on 57,975 Voy participants showing 53% more weight loss vs medication-only providers.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Academic partnership for research and clinical validation of GLP-1 obesity care programs.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Academic partnership for research collaboration in obesity care and digital health.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

International academic partnership in Brazil for obesity research and clinical validation.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Academic partnership for research collaboration in digital health and weight management.

7University of Hertfordshire
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Academic partnership for research and clinical studies in obesity care.

joinvoy.in
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

India's leading digital pharmacy and telehealth platform with diagnostic and consultation services. Broadly comparable as a scaled Indian digital health ecosystem that could enter the weight loss category.

TypeBroad incumbent
Description

India's largest doctor appointment and telehealth platform serving 100M+ consumers. Comparable as a scaled Indian telehealth infrastructure that overlaps with the medical consultation and prescription layer of EarlyFit/Voy India's offering.

TypeDirect peer
Description

India's leading digital health and weight loss platform offering AI-powered nutrition tracking, coaching, and now GLP-1 programs. Directly comparable as a doctor-supervised weight loss ecosystem serving the same Indian consumer base.

TypeDirect peer
Description

US digital weight loss clinic combining GLP-1 medication with coaching and metabolic reset programs. Closely comparable in clinical positioning, subscription pricing, and outcome-based guarantees.

TypeDirect peer
Description

London-based parent company of EarlyFit operating the same GLP-1 weight loss program across UK, Germany, Brazil, and now India. Same product, brand, and clinical model — effectively the global version of the EarlyFit platform.

TypeDirect peer
Description

US-based digital weight loss clinic offering medication (including GLP-1s) with clinical oversight and coaching. Closely comparable business model with subscription-based, doctor-supervised GLP-1 delivery.

7Noom
TypeDirect peer
Description

Global digital weight loss platform combining psychology-based coaching with calorie tracking and now GLP-1 support. Direct competitor in the behavioral coaching + medication weight loss category with comparable subscription model.

TypeBroad incumbent
Description

India's largest fitness and wellness platform offering gym memberships, nutrition, and mental health services. Expanding into clinical health, broadly comparable as a vertically-integrated consumer health platform targeting urban Indians.

9Ro
TypeDirect peer
Description

US telehealth platform offering direct-to-consumer weight loss programs with GLP-1 prescriptions, lab testing, and ongoing care. Direct comparable in the integrated telehealth + medication + coaching category.

TypeBroad incumbent
Description

US telehealth leader offering branded GLP-1 weight loss programs alongside broader wellness categories. Comparable as a scaled, vertically-integrated telehealth consumer health platform.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

EarlyFit

Digital Health / Telehealth Weight Managementearly.fit

EarlyFit, now Voy India following Voy's June 2026 acquisition, runs a doctor-led digital GLP-1 weight loss platform serving India's 150 million obese population with endocrinologist consultations, cold-chain generic semaglutide delivery, and smart scale-integrated mobile app tracking.

What EarlyFit does

EarlyFit, now operating as Voy India following its June 2026 acquisition by London-based Voy, runs a doctor-led digital weight loss platform that delivers GLP-1 obesity care to India's 150 million obese population. The core offering combines an online eligibility assessment, endocrinologist-led consultations, at-home cold-chain delivery of generic semaglutide medication, lifestyle coaching, at-home lab testing, and a companion mobile app with smart scale integration tracking 14+ body vitals. The business model is subscription-recurring, with bundled pricing that covers medication, ongoing medical oversight, and lifestyle support, backed by a money-back guarantee requiring 10% body weight loss within six months.

Founded by Parth and Saloni as one of India's first doctor-led GLP-1 ecosystems, EarlyFit was fully acquired by Voy on 2026-06-08 to bring Voy's global clinical expertise and integrated care model into the Indian market, timed to capitalize on the March 2026 expiration of Ozempic's patent in India. The medical team comprises senior endocrinologists trained at India's premier institutions — Apollo Delhi, AIIMS Delhi, AIIMS Jodhpur, Army Hospital, and Safdarjung — and global medical leadership under Dr. Earim Chaudry (Chief Medical Officer, Voy) and Dr. Saptarshi Bhattacharya (Chief Medical Advisor, Voy India). A clinical study of 57,975 Voy participants conducted with Imperial College London reports 53% more weight loss for Voy program users compared with medication-only treatment.

Go-to-market is product-led and digital: customers self-check eligibility online, download the mobile app (iOS/Android), enroll via subscription without sales intervention, and receive medication via door-to-door cold chain delivery. Distribution layers in doctor-consultation marketing and earned media across Indian publications (Indian Express, Times of India, Hindustan Times, News18, BioSpectrum India), with Trustpilot (4.7/5, 18k reviews) and App Store (4.8/5, 4.2k reviews) ratings functioning as trust signals. Strategic academic partnerships span Imperial College London, University of Oxford, University of Birmingham, Ulster University, University of Hertfordshire, and the Federal University of Minas Gerais, supporting clinical validation across Voy's four-country footprint (UK, Germany, Brazil, India).

EarlyFit firmographics

Firmographics
Name
EarlyFit
Legal name
EarlyFit
Website
https://early.fit
Company type
Private
Founded year
2025
Operating status
Acquired
Headcount range
1–10 employees
Short description
EarlyFit, now Voy India following Voy's June 2026 acquisition, runs a doctor-led digital GLP-1 weight loss platform serving India's 150 million obese population with endocrinologist consultations, cold-chain generic semaglutide delivery, and smart scale-integrated mobile app tracking.
Ownership category
akta.pro rank

EarlyFit industry classification

Industry
Product category
Digital Health / Telehealth Weight Management
NAICS
Diet and Weight Reducing Centers (812191)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Home Health Care Services (8082)
akta.pro industry
PRIMARYHSADAFAB
Weight Loss Coaching (Non-Clinical)

Keywords

  • Online weight loss program
  • GLP-1 medication treatment
  • Telehealth weight management
  • Digital obesity care
  • Doctor-supervised weight loss

Where EarlyFit is headquartered

Location

Headquarters

HQ city
New Delhi
HQ country
India
HQ region
Asia

Markets served

EarlyFit business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Supply Chain, Others

Revenue model

  1. GLP-1 Medication Subscription: Recurring subscription for GLP-1 medication (generic semaglutide) delivered to patients. Program includes doctor consultations, at-home medication delivery, side effect support, and lifestyle coaching. Following Ozempic's patent expiration in India in March 2026, affordable generic options are offered.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

EarlyFit product offering

Product offering

Core offering

EarlyFit is an online, doctor-supervised weight loss platform based in India that combines GLP-1 (semaglutide-based) medication programs with teleconsultations, at-home lab testing, and lifestyle coaching. The service delivers end-to-end obesity care via a mobile app and website, targeting individual adults seeking clinically-supervised weight management. Following its June 2026 acquisition by London-headquartered Voy, the offering now operates as Voy India.

Product overview

EarlyFit operates as a comprehensive digital weight loss platform offering a doctor-led GLP-1 obesity care program. The platform combines an online weight loss platform with mobile app functionality, providing medical consultations with endocrinologists, at-home GLP-1 medication delivery via cold chain, lifestyle coaching, smart body tracking, and at-home lab testing. Following its acquisition by UK-based Voy, the program now offers affordable generic semaglutide medications with a 10% body weight loss money-back guarantee.

Differentiator

Problem solved

Functional benefit

Products and services

  • GLP-1 Weight Loss Program A structured, doctor-supervised treatment program using GLP-1 receptor agonist medication (semaglutide) for adults with overweight or obesity, including an initial consultation, prescription, follow-ups, and lifestyle coaching. Target users are individual consumers in India seeking medical weight loss.
  • EarlyFit Mobile App A consumer mobile app that allows enrolled users to register, complete telehealth consultations with clinicians, track weight-loss progress, access coaching, and manage their treatment plan. Targeted at individual program participants in India.
  • At-Home Lab Testing A home-based diagnostic testing service that collects blood and metabolic markers from enrolled users to support safe prescribing and progress monitoring of the weight loss program. Target users are individual program participants.
  • Lifestyle Coaching Program A digital lifestyle coaching program providing nutritional guidance, activity planning, and habit-change support to complement medical treatment. Targeted at individual adults enrolled in the weight loss program.
  • Generic Semaglutide Medication Generic semaglutide medication dispensed under clinician prescription to enrolled users as part of the weight loss program. Targeted at individual patients medically cleared for GLP-1 therapy.

Quantifiable outcome

  • 53% more weight loss compared to medication-only providers
  • +2 more outcomes

Companies that use EarlyFit

Customer profile

Named customers4 records

Segments2 records

Ideal customer profiles1 record

EarlyFit technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

EarlyFit partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and flagship.

  • VoycoreStrategic or Co-development Partner · 8 June 2026Voy, a London-headquartered digital healthcare company and market leader in GLP-1 obesity care, acquired 100% of EarlyFit to enter the Indian market. The acquisition brings Voy's global clinical expertise, technology, and integrated care model to India's 150 million obese population.
  • Imperial College LondoncoreStrategic or Co-development PartnerResearch partnership for clinical studies on GLP-1 weight loss outcomes. Conducted study on 57,975 Voy participants showing 53% more weight loss vs medication-only providers.
  • University of OxfordflagshipStrategic or Co-development PartnerAcademic partnership for research and clinical validation of GLP-1 obesity care programs.
  • University of BirminghamflagshipStrategic or Co-development PartnerAcademic partnership for research collaboration in obesity care and digital health.
  • Federal University of Minas GeraisflagshipStrategic or Co-development PartnerInternational academic partnership in Brazil for obesity research and clinical validation.
  • Ulster UniversityflagshipStrategic or Co-development PartnerAcademic partnership for research collaboration in digital health and weight management.
  • University of HertfordshireflagshipStrategic or Co-development PartnerAcademic partnership for research and clinical studies in obesity care.

Scale indicators7 records

Recent moves5 records

Expansion highlights5 records

EarlyFit competitors and assessment

Company assessment

Broad incumbents

  • Tata 1mg: India's leading digital pharmacy and telehealth platform with diagnostic and consultation services. Broadly comparable as a scaled Indian digital health ecosystem that could enter the weight loss category.
  • Practo: India's largest doctor appointment and telehealth platform serving 100M+ consumers. Comparable as a scaled Indian telehealth infrastructure that overlaps with the medical consultation and prescription layer of EarlyFit/Voy India's offering.
  • Cult.fit (Cure.fit): India's largest fitness and wellness platform offering gym memberships, nutrition, and mental health services. Expanding into clinical health, broadly comparable as a vertically-integrated consumer health platform targeting urban Indians.
  • Hims & Hers Health: US telehealth leader offering branded GLP-1 weight loss programs alongside broader wellness categories. Comparable as a scaled, vertically-integrated telehealth consumer health platform.

Direct peers

  • HealthifyMe: India's leading digital health and weight loss platform offering AI-powered nutrition tracking, coaching, and now GLP-1 programs. Directly comparable as a doctor-supervised weight loss ecosystem serving the same Indian consumer base.
  • Calibrate: US digital weight loss clinic combining GLP-1 medication with coaching and metabolic reset programs. Closely comparable in clinical positioning, subscription pricing, and outcome-based guarantees.
  • Voy: London-based parent company of EarlyFit operating the same GLP-1 weight loss program across UK, Germany, Brazil, and now India. Same product, brand, and clinical model — effectively the global version of the EarlyFit platform.
  • Found: US-based digital weight loss clinic offering medication (including GLP-1s) with clinical oversight and coaching. Closely comparable business model with subscription-based, doctor-supervised GLP-1 delivery.
  • Noom: Global digital weight loss platform combining psychology-based coaching with calorie tracking and now GLP-1 support. Direct competitor in the behavioral coaching + medication weight loss category with comparable subscription model.
  • Ro: US telehealth platform offering direct-to-consumer weight loss programs with GLP-1 prescriptions, lab testing, and ongoing care. Direct comparable in the integrated telehealth + medication + coaching category.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

EarlyFit financial estimates

Financial estimate

Revenue estimate

Valuation estimate

EarlyFit leadership team

Management profile

Number of profiles

Profiles5 records

EarlyFit funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

EarlyFit M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EarlyFit

What does EarlyFit do?

EarlyFit is an online, doctor-supervised weight loss platform based in India that combines GLP-1 (semaglutide-based) medication programs with teleconsultations, at-home lab testing, and lifestyle coaching. The service delivers end-to-end obesity care via a mobile app and website, targeting individual adults seeking clinically-supervised weight management. Following its June 2026 acquisition by London-headquartered Voy, the offering now operates as Voy India.

Is EarlyFit a public or private company?

EarlyFit is a private company. It is classified as corporate owned and is currently acquired.

When was EarlyFit founded?

EarlyFit was founded in 2025. It employs 1 to 10 people.

Where is EarlyFit based?

EarlyFit is headquartered in New Delhi, India, in the Asia region.

How does EarlyFit make money?

One revenue line is on record: GLP-1 Medication Subscription.

Who are EarlyFit's main competitors?

Broad incumbents on record are Tata 1mg, Practo, Cult.fit (Cure.fit) and Hims & Hers Health. Direct peers are HealthifyMe, Calibrate, Voy, Found, Noom and Ro.

Does EarlyFit have an API?

No public API is recorded for EarlyFit.

What industry is EarlyFit in?

EarlyFit's product category is Digital Health / Telehealth Weight Management. Its primary akta.pro industry code is HSADAFAB, Weight Loss Coaching (Non-Clinical). Its NAICS code is 812191 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The TribuneUK Digital Health Leader Voy Enters India Through 100% Acquisition of EarlyFit, Strengthening Presence in the Fast-Growing Indian Obesity Care MarketVoy, a London-headquartered digital healthcare company and market leader in GLP-1 obesity care, announced its entry into India through the 100% acquisition of EarlyFit, one of India's leading online weight loss platforms. The acquisition targets India's 150 million obese population and brings Voy's global clinical expertise, technology, and integrated care model to what it describes as one of the world's largest and fastest-growing healthcare markets. Voy India will initially focus on weight loss and obesity care, launching with affordable generic semaglutide offerings following Ozempic's patent expiration in India in March 2026.Elets BFSIUK Digital Health Firm Voy Enters India Through EarlyFit Acquisition to Tap Growing Obesity Care MarketVoy, a UK digital health firm, entered India by acquiring EarlyFit, an online weight-loss platform. The move targets India's growing obesity care market, with plans to offer generic semaglutide therapies. Voy aims to expand into adjacent segments like dermatology and hormonal health.VCCirclePramatra Space, GIVA, TIST snag funding; Ziptrrip, Voy strike M&AsPramatra Space, GIVA, and TIST raised early-stage funding, while Ziptrrip and Voy completed acquisitions. Pramatra Space raised an undisclosed pre-seed amount led by Seafund Ventures; GIVA's terms were undisclosed; TIST's seed round valued it at $5.9 million. Ziptrrip acquired HelloTravel Online, and Voy acquired EarlyFit to enter India.LevinassociatesVoy Enters India’s Obesity Care Market With EarlyFit AcquisitionVoy, a London-based digital healthcare company, acquired EarlyFit, an online weight-loss platform, to enter India's obesity care market. The acquisition will rebrand EarlyFit as Voy India, with clinical leadership from EarlyFit co-founders and Voy's GLP-1-led care model. Voy India will initially focus on obesity treatment before expanding into other categories.JoinvoyPress & MediaVoy, a UK digital health company, acquired EarlyFit to launch Voy India, expanding GLP-1 weight loss care nationwide. The company has served over 2 million patients globally, with a recent semaglutide patent expiry expected to broaden access. Voy plans to expand into broader therapeutic areas over time.